K. Ahn, A. Angulo, P. Ghazal, P. A. Peterson, Y. Yang et al., Human cytomegalovirus inhibits antigen presentation by a sequential multistep process., Proc Natl Acad Sei US A 93, pp.10990-10995, 1996.
DOI : 10.1073/pnas.93.20.10990

C. Bais, B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka et al., Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator, Nature, vol.391, issue.6672, pp.210-86, 1998.
DOI : 10.1038/32472

D. Benjamin, T. J. Knobloch, and M. A. Dayton, Human B Cell Interleukin 10, Leukemia & Lymphoma, vol.80, issue.3-4, pp.1289-98, 1992.
DOI : 10.1172/JCI114678

J. Y. Blay, N. Burdin, F. Rousset, G. Lenoir, P. Biron et al., Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor, Blood, vol.82, pp.2169-74, 1993.

B. Bodaghi, T. R. Jones, D. Zipeto, C. Vita, L. Sun et al., Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells, The Journal of Experimental Medicine, vol.59, issue.5, pp.855-66, 1998.
DOI : 10.1146/annurev.immunol.15.1.675

N. Burdin, C. Peronne, J. Banchereau, R. , and F. , Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10, Journal of Experimental Medicine, vol.177, issue.2, pp.295-304, 1993.
DOI : 10.1084/jem.177.2.295

C. Cayrol and E. K. Flemington, Identification of cellular target genes of the, 1995.

Y. N. Chang, D. L. Dong, G. S. Hayward, H. , and S. D. , The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif, J Virol, vol.64, pp.3358-69, 1990.

M. Clerici, T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix et al., Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus., Journal of Clinical Investigation, vol.93, issue.2, pp.768-75, 1994.
DOI : 10.1172/JCI117031

J. I. Cohen, Epstein???Barr Virus Infection, New England Journal of Medicine, vol.343, issue.7, pp.481-92, 2000.
DOI : 10.1056/NEJM200008173430707

E. P. Cowan, R. K. Alexander, S. Daniel, F. Kashanchi, and J. N. Brady, Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax, J Virol, vol.71, pp.6982-6991, 1997.

M. A. Cox, J. Leahy, and J. M. Hardwick, An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the Rand Z transactivators, J Virol, vol.64, pp.313-334, 1990.

1. Interleukin, IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J Exp Med, vol.174, pp.1209-1229

D. Derossi, A. H. Joliot, G. Chassaing, and A. Prochiantz, The third helix of the Antennapedia homeodomain translocates through biological membranes, J Biol Chem, vol.269, pp.10444-50, 1994.

A. Elsing and H. G. Burgert, The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization, Proc Natl Acad Sei U S A 95, pp.10072-10079, 1998.
DOI : 10.1073/pnas.95.17.10072

J. Eskdale, D. Kube, H. Tesch, and G. Gallagher, Mapping of the human IL10 gene and further characterization of the 5' flanking sequence, Immunogenetics, vol.46, issue.2, pp.120-128, 1997.
DOI : 10.1007/s002510050250

H. Fahmi, C. Cochet, Z. Hmama, P. Opolon, J. et al., Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLFl immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway, J Virol, vol.74, 2000.

P. J. Farrell, D. T. Rowe, C. M. Rooney, and T. Kouzarides, Epstein-Barr virus BZLFl trans-activator specifically binds to a consensus AP-1 site and is related to c-fos, Embo J, vol.8, pp.127-159, 1989.

E. Flemington and S. H. Speck, Epstein-Barr virus BZLFl trans activator induces the promoter of a cellular cognate gene, c-fos, J Virol, vol.64, pp.4549-52, 1990.

E. K. Flemington, A. M. Borras, J. P. Lytle, and S. H. Speck, Characterization of the Epstein-Barr virus BZLFl protein transactivation domain, J Virol, vol.66, pp.922-931, 1992.

J. L. Garnier, N. Blanc-brunat, G. Vivier, F. Rousset, and J. L. Touraine, Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas, Clinical Transplantation, vol.324, issue.4, pp.305-317, 1999.
DOI : 10.1016/S0140-6736(95)91150-2

M. Gstaiger, C. Hovens, O. Georgiev, L. Knoepfel, and W. Schaffner, BZLFl (ZEBRA, Zta) protein of Epstein-Barr virus selected in a yeast one-hybrid system by binding to a consensus site in the IgH intronic enhancer: arole in immunoglobulin expression?, Biol Chem, vol.377, pp.669-73, 1996.

P. Guermonprez, D. Ladant, C. Fayolle, A. Ullmann, and C. Leclerc, Les toxines bact??riennes recombinantes: de nouveaux vecteurs pour la vaccination ?, m??decine/sciences, vol.16, issue.5, pp.653-62, 2000.
DOI : 10.4267/10608/1708

K. Kanda, T. Decker, P. Aman, M. Wahlstrom, A. Von-gabain et al., The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effecis induction of IFN-induced genes but not the activation of transcription factor ISGF-3 [published erratum appears in, Mol Cell Biol Mol Cell Biol, vol.3, issue.12, pp.1981-4930, 1992.

V. P. Khatri and M. A. Caligiuri, A review of the association between interleukin-10 and human B-cell malignancies, Cancer Immunology, Immunotherapy, vol.46, issue.5, pp.239-283, 1998.
DOI : 10.1007/s002620050483

D. T. Kim, D. J. Mitchell, D. G. Brockstedt, L. Fong, G. P. Nolan et al., Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide, J Immunol, vol.15, issue.9, pp.1666-1674, 1997.

T. N. Kledal, M. M. Rosenkilde, F. Coulin, G. Simmons, A. H. Johnsen et al., A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated Herpesvirus, Science, vol.277, issue.5332, pp.1656-1665, 1997.
DOI : 10.1126/science.277.5332.1656

S. C. Klein, D. Kube, H. Abts, V. Diehl, and H. Tesch, Promotion of IL8, IL10, TNF?? and TNF?? production by EBV infection, Leukemia Research, vol.20, issue.8, pp.633-639, 1996.
DOI : 10.1016/0145-2126(96)00029-X

G. T. Leonard and G. C. Sen, Effects of adenovirus El A protein on interferon-signaling, 1996.

M. Li, H. Lee, J. Guo, F. Neipel, B. Fleckenstein et al., Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor, J Virol, vol.72, pp.5433-5473, 1998.

P. M. Lieberrnan, J. M. Hardwick, H. , and S. D. , Responsiveness of the, 1989.

P. M. Lieberrnan, J. M. Hardwick, J. Sample, G. S. Hayward, H. et al., The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virusinfected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions, 1990.

P. M. Lieberman, J. Ozer, and D. B. Gursel, Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition., Molecular and Cellular Biology, vol.17, issue.11, pp.6624-6656, 1997.
DOI : 10.1128/MCB.17.11.6624

D. A. Mann and A. D. Frankel, Endocytosis and targeting of exogenous HIV-1 Tat protein, Embo J, vol.10, pp.1733-1742, 1991.

C. G. Miller, S. N. Shchelkunov, and G. J. Kotwal, The Cowpox Virus-Encoded Homolog of the Vaccinia Virus Complement Control Protein Is an Inflammation Modulatory Protein, Virology, vol.229, issue.1, 1997.
DOI : 10.1006/viro.1996.8396

D. M. Miller, B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin et al., Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway, The Journal of Experimental Medicine, vol.158, issue.5, pp.675-83, 1998.
DOI : 10.1016/S1074-7613(00)80349-0

C. Montpellier, H. Groux, C. Auriault, and J. Coll, Lymphoprolif??rations T associ??es au virus d'Epstein-Barr., m??decine/sciences, vol.14, issue.6-7, pp.690-697, 1998.
DOI : 10.4267/10608/1123

F. Neipel, J. C. Albrecht, and B. Fleckenstein, Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?, J Virol, vol.71, pp.4187-92, 1997.

A. Phelan, G. Elliott, O. Hare, and P. , Intercellular delivery of functional p53 by the herpesvirus protein VP22, Nature Biotechnology, vol.39, issue.5, pp.440-443, 1998.
DOI : 10.1006/viro.1996.0286

V. Piguet, O. Schwartz, L. Gall, S. Trono, and D. , The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors, Immunological Reviews, vol.271, issue.1, pp.51-63, 1999.
DOI : 10.1083/jcb.136.4.811

URL : https://hal.archives-ouvertes.fr/pasteur-01372749

M. Raphaël, Virus d'Epstein-Barr et lymphomes. La lettre de l'infectiologue 10, pp.202-207, 1995.

D. Reinhold, S. Wrenger, T. Kahne, and S. Ansorge, HIV-1 Tat: immunosuppression via TGF-??1 induction, Immunology Today, vol.20, issue.8, pp.384-389, 1999.
DOI : 10.1016/S0167-5699(99)01497-8

H. T. Reyburn, O. Mandelboim, M. Vales-gomez, D. M. Davis, L. Pazmany et al., The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells, Nature, vol.386, issue.6624, pp.514-521, 1997.
DOI : 10.1038/386514a0

A. B. Rickinson and E. Kieff, Epstein???Barr virus, Virus Research, vol.82, issue.1-2, 1996.
DOI : 10.1016/S0168-1702(01)00436-1

URL : https://hal.archives-ouvertes.fr/inserm-00508046

K. L. Rock and A. L. Goldberg, DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES, Annual Review of Immunology, vol.17, issue.1, pp.739-79, 1999.
DOI : 10.1146/annurev.immunol.17.1.739

F. Rousset, E. Garcia, T. Defrance, C. Peronne, N. Vezzio et al., Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes., Proc Natl Acad Sei US A, pp.1890-1893, 1992.
DOI : 10.1073/pnas.89.5.1890

T. Sairenji, E. Ohnishi, S. Inouye, and T. Kurata, Induction of Interleukin-10 on Activation of Epstein-Barr Virus in EBV-Infected B-Cell Lines, Viral Immunology, vol.11, issue.4, pp.221-252, 1998.
DOI : 10.1089/vim.1998.11.221

M. P. Schutze-redelmeier, H. Gournier, F. Garcia-pons, M. Moussa, A. H. Joliot et al., Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo, J Immunol, vol.157, pp.650-655, 1996.

S. R. Schwarze, A. Ho, A. Vocero-akbani, and S. F. Dowdy, In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse, Science, vol.285, issue.5433, pp.1569-72, 1999.
DOI : 10.1126/science.285.5433.1569

J. Seigneurin, Infection à virus d'Epstein-Barr chez l'immunodéprimé physiopatholgie et méthodes d'analyse, Virologie, vol.1, pp.391-402, 1997.

A. Sergeant, The Epstein-Barr virus latency and reactivation. In Cancer in Transplantation : Prevention and Treatment, J. L. Touraine, J. Traeger, H. Bétuel, J. M, 1996.

S. H. Speck, T. Chatila, and E. Flemington, Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene, Trends in Microbiology, vol.5, issue.10, pp.399-405, 1997.
DOI : 10.1016/S0966-842X(97)01129-3

P. G. Stevenson, S. Efstathiou, P. C. Doherty, and P. J. Lehner, Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses, Proc Natl Acad Sei U S A 97, pp.8455-60, 2000.
DOI : 10.1073/pnas.150240097

J. A. Symons, A. Alcami, and G. L. Smith, Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity, Cell, vol.81, issue.4, pp.551-60, 1995.
DOI : 10.1016/0092-8674(95)90076-4

H. Taga, K. Taga, F. Wang, J. Chretien, and G. Tosato, Human and Viral Interleukin-10 in Acute Epstein-Barr Virus-Induced Infectious Mononucleosis, Journal of Infectious Diseases, vol.171, issue.5, pp.7-50, 1995.
DOI : 10.1093/infdis/171.5.1347

K. Taga, H. Mostowski, and G. Tosato, Human interleukin-10 can directly inhibit T-cell growth, Blood, vol.81, pp.2964-71, 1993.

A. Tedgui and Z. Mallat, Athérosclérose : les pouvoirs de !'interleukine 1 O, Inserm actualités, p.5, 2000.

D. Tortorella, B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh, Viral Subversion of the Immune System, Annual Review of Immunology, vol.18, issue.1, pp.861-926, 2000.
DOI : 10.1146/annurev.immunol.18.1.861

G. Urier, M. Buisson, P. Chambard, and A. Sergeant, The Epstein-Barr virus early protein EB 1 activates transcription from different responsive elements including AP-1 binding sites, Embo J, vol.8, pp.1447-53, 1989.

N. Voorzanger and J. Blay, Interleukin 10 and non Hodgkin???s lymphomas, Cancer in, pp.229-241, 1996.
DOI : 10.1007/978-94-009-0175-9_26

N. Voorzanger, R. Touitou, M. C. Favrot, I. Joab, L. Edelman et al., Correlation between IL-10 expression and the presence of EBV in non Hodgkin's lymphoma, Blood, vol.84, p.59, 1994.

C. Wanidworanun and W. Strober, Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis, J Immunol, vol.151, pp.6853-61, 1993.